nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylate-sodium—PTGS2—Etoposide—sarcoma	0.264	0.542	CbGbCtD
Salicylate-sodium—PTGS1—Etoposide—sarcoma	0.223	0.458	CbGbCtD
Salicylate-sodium—PTGS2—periosteum—sarcoma	0.0121	0.125	CbGeAlD
Salicylate-sodium—PTGS2—leg—sarcoma	0.00968	0.0995	CbGeAlD
Salicylate-sodium—PTGS2—hindlimb—sarcoma	0.00864	0.0889	CbGeAlD
Salicylate-sodium—Acetylsalicylic acid—TP53—sarcoma	0.00851	1	CrCbGaD
Salicylate-sodium—PTGS2—cartilage tissue—sarcoma	0.00851	0.0875	CbGeAlD
Salicylate-sodium—PTGS2—appendage—sarcoma	0.00741	0.0762	CbGeAlD
Salicylate-sodium—PTGS1—endothelium—sarcoma	0.00468	0.0481	CbGeAlD
Salicylate-sodium—PTGS2—endothelium—sarcoma	0.00447	0.046	CbGeAlD
Salicylate-sodium—PTGS2—myometrium—sarcoma	0.00256	0.0263	CbGeAlD
Salicylate-sodium—PTGS2—embryo—sarcoma	0.00246	0.0253	CbGeAlD
Salicylate-sodium—PTGS1—seminal vesicle—sarcoma	0.00242	0.0249	CbGeAlD
Salicylate-sodium—PTGS2—seminal vesicle—sarcoma	0.00231	0.0238	CbGeAlD
Salicylate-sodium—PTGS1—hematopoietic system—sarcoma	0.0023	0.0236	CbGeAlD
Salicylate-sodium—PTGS1—connective tissue—sarcoma	0.00221	0.0228	CbGeAlD
Salicylate-sodium—PTGS2—hematopoietic system—sarcoma	0.0022	0.0226	CbGeAlD
Salicylate-sodium—PTGS2—connective tissue—sarcoma	0.00212	0.0218	CbGeAlD
Salicylate-sodium—PTGS1—smooth muscle tissue—sarcoma	0.00202	0.0208	CbGeAlD
Salicylate-sodium—PTGS1—skin of body—sarcoma	0.002	0.0206	CbGeAlD
Salicylate-sodium—PTGS2—smooth muscle tissue—sarcoma	0.00194	0.0199	CbGeAlD
Salicylate-sodium—PTGS2—skin of body—sarcoma	0.00191	0.0196	CbGeAlD
Salicylate-sodium—PTGS1—cardiac atrium—sarcoma	0.00175	0.018	CbGeAlD
Salicylate-sodium—PTGS1—uterus—sarcoma	0.00174	0.0179	CbGeAlD
Salicylate-sodium—PTGS2—uterus—sarcoma	0.00166	0.0171	CbGeAlD
Salicylate-sodium—PTGS2—lymphoid tissue—sarcoma	0.00155	0.0159	CbGeAlD
Salicylate-sodium—PTGS1—tendon—sarcoma	0.00152	0.0156	CbGeAlD
Salicylate-sodium—PTGS2—tendon—sarcoma	0.00145	0.015	CbGeAlD
Salicylate-sodium—PTGS2—bone marrow—sarcoma	0.00141	0.0145	CbGeAlD
Salicylate-sodium—PTGS1—testis—sarcoma	0.00126	0.013	CbGeAlD
Salicylate-sodium—PTGS2—liver—sarcoma	0.00114	0.0117	CbGeAlD
Salicylate-sodium—PTGS1—lymph node—sarcoma	0.000913	0.00939	CbGeAlD
Salicylate-sodium—PTGS2—lymph node—sarcoma	0.000873	0.00898	CbGeAlD
Salicylate-sodium—Paraesthesia—Thiotepa—sarcoma	0.000861	0.00212	CcSEcCtD
Salicylate-sodium—Anxiety—Mitoxantrone—sarcoma	0.000861	0.00212	CcSEcCtD
Salicylate-sodium—Somnolence—Thiotepa—sarcoma	0.000852	0.00209	CcSEcCtD
Salicylate-sodium—Renal failure acute—Epirubicin—sarcoma	0.000851	0.00209	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Vincristine—sarcoma	0.00085	0.00209	CcSEcCtD
Salicylate-sodium—Oedema—Vincristine—sarcoma	0.00085	0.00209	CcSEcCtD
Salicylate-sodium—Infection—Vincristine—sarcoma	0.000845	0.00208	CcSEcCtD
Salicylate-sodium—Dyspepsia—Thiotepa—sarcoma	0.000844	0.00207	CcSEcCtD
Salicylate-sodium—Phlebitis—Doxorubicin—sarcoma	0.000844	0.00207	CcSEcCtD
Salicylate-sodium—Confusional state—Mitoxantrone—sarcoma	0.000835	0.00205	CcSEcCtD
Salicylate-sodium—Decreased appetite—Thiotepa—sarcoma	0.000833	0.00205	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Mitoxantrone—sarcoma	0.000828	0.00203	CcSEcCtD
Salicylate-sodium—Oedema—Mitoxantrone—sarcoma	0.000828	0.00203	CcSEcCtD
Salicylate-sodium—Decreased appetite—Dactinomycin—sarcoma	0.000827	0.00203	CcSEcCtD
Salicylate-sodium—Fatigue—Thiotepa—sarcoma	0.000827	0.00203	CcSEcCtD
Salicylate-sodium—Dysgeusia—Etoposide—sarcoma	0.000826	0.00203	CcSEcCtD
Salicylate-sodium—Renal impairment—Epirubicin—sarcoma	0.000825	0.00203	CcSEcCtD
Salicylate-sodium—Infection—Mitoxantrone—sarcoma	0.000822	0.00202	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Vincristine—sarcoma	0.000822	0.00202	CcSEcCtD
Salicylate-sodium—Fatigue—Dactinomycin—sarcoma	0.00082	0.00202	CcSEcCtD
Salicylate-sodium—Pain—Thiotepa—sarcoma	0.00082	0.00201	CcSEcCtD
Salicylate-sodium—Constipation—Thiotepa—sarcoma	0.00082	0.00201	CcSEcCtD
Salicylate-sodium—Shock—Mitoxantrone—sarcoma	0.000814	0.002	CcSEcCtD
Salicylate-sodium—Pain—Dactinomycin—sarcoma	0.000814	0.002	CcSEcCtD
Salicylate-sodium—Anorexia—Vincristine—sarcoma	0.00081	0.00199	CcSEcCtD
Salicylate-sodium—Tachycardia—Mitoxantrone—sarcoma	0.000808	0.00199	CcSEcCtD
Salicylate-sodium—Cerebrovascular accident—Epirubicin—sarcoma	0.000801	0.00197	CcSEcCtD
Salicylate-sodium—Lethargy—Epirubicin—sarcoma	0.000801	0.00197	CcSEcCtD
Salicylate-sodium—Cardiac failure congestive—Doxorubicin—sarcoma	0.000801	0.00197	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Mitoxantrone—sarcoma	0.0008	0.00197	CcSEcCtD
Salicylate-sodium—Hypotension—Vincristine—sarcoma	0.000794	0.00195	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Thiotepa—sarcoma	0.00079	0.00194	CcSEcCtD
Salicylate-sodium—Anorexia—Mitoxantrone—sarcoma	0.000789	0.00194	CcSEcCtD
Salicylate-sodium—Renal failure acute—Doxorubicin—sarcoma	0.000787	0.00193	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Dactinomycin—sarcoma	0.000784	0.00193	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Thiotepa—sarcoma	0.000784	0.00193	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Dactinomycin—sarcoma	0.000778	0.00191	CcSEcCtD
Salicylate-sodium—Hypotension—Mitoxantrone—sarcoma	0.000774	0.0019	CcSEcCtD
Salicylate-sodium—Renal impairment—Doxorubicin—sarcoma	0.000764	0.00188	CcSEcCtD
Salicylate-sodium—Paraesthesia—Vincristine—sarcoma	0.000763	0.00188	CcSEcCtD
Salicylate-sodium—Urticaria—Thiotepa—sarcoma	0.000762	0.00187	CcSEcCtD
Salicylate-sodium—Body temperature increased—Thiotepa—sarcoma	0.000758	0.00186	CcSEcCtD
Salicylate-sodium—Abdominal pain—Thiotepa—sarcoma	0.000758	0.00186	CcSEcCtD
Salicylate-sodium—Abdominal pain—Dactinomycin—sarcoma	0.000752	0.00185	CcSEcCtD
Salicylate-sodium—Body temperature increased—Dactinomycin—sarcoma	0.000752	0.00185	CcSEcCtD
Salicylate-sodium—Paraesthesia—Mitoxantrone—sarcoma	0.000743	0.00183	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Etoposide—sarcoma	0.000742	0.00182	CcSEcCtD
Salicylate-sodium—Lethargy—Doxorubicin—sarcoma	0.000742	0.00182	CcSEcCtD
Salicylate-sodium—Cerebrovascular accident—Doxorubicin—sarcoma	0.000742	0.00182	CcSEcCtD
Salicylate-sodium—Decreased appetite—Vincristine—sarcoma	0.000739	0.00182	CcSEcCtD
Salicylate-sodium—Dyspnoea—Mitoxantrone—sarcoma	0.000738	0.00181	CcSEcCtD
Salicylate-sodium—Somnolence—Mitoxantrone—sarcoma	0.000736	0.00181	CcSEcCtD
Salicylate-sodium—Blood creatinine increased—Epirubicin—sarcoma	0.000736	0.00181	CcSEcCtD
Salicylate-sodium—Fatigue—Vincristine—sarcoma	0.000733	0.0018	CcSEcCtD
Salicylate-sodium—Convulsion—Etoposide—sarcoma	0.000731	0.0018	CcSEcCtD
Salicylate-sodium—Dehydration—Epirubicin—sarcoma	0.00073	0.0018	CcSEcCtD
Salicylate-sodium—Dyspepsia—Mitoxantrone—sarcoma	0.000729	0.00179	CcSEcCtD
Salicylate-sodium—Pain—Vincristine—sarcoma	0.000727	0.00179	CcSEcCtD
Salicylate-sodium—Constipation—Vincristine—sarcoma	0.000727	0.00179	CcSEcCtD
Salicylate-sodium—Decreased appetite—Mitoxantrone—sarcoma	0.00072	0.00177	CcSEcCtD
Salicylate-sodium—Chest pain—Etoposide—sarcoma	0.000718	0.00177	CcSEcCtD
Salicylate-sodium—Abdominal pain upper—Epirubicin—sarcoma	0.000717	0.00176	CcSEcCtD
Salicylate-sodium—Hypokalaemia—Epirubicin—sarcoma	0.000715	0.00176	CcSEcCtD
Salicylate-sodium—Fatigue—Mitoxantrone—sarcoma	0.000714	0.00175	CcSEcCtD
Salicylate-sodium—Pain—Mitoxantrone—sarcoma	0.000708	0.00174	CcSEcCtD
Salicylate-sodium—Constipation—Mitoxantrone—sarcoma	0.000708	0.00174	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Thiotepa—sarcoma	0.000706	0.00174	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Dactinomycin—sarcoma	0.000701	0.00172	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Vincristine—sarcoma	0.000695	0.00171	CcSEcCtD
Salicylate-sodium—Confusional state—Etoposide—sarcoma	0.000694	0.00171	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Etoposide—sarcoma	0.000689	0.00169	CcSEcCtD
Salicylate-sodium—Asthenia—Thiotepa—sarcoma	0.000688	0.00169	CcSEcCtD
Salicylate-sodium—Infection—Etoposide—sarcoma	0.000684	0.00168	CcSEcCtD
Salicylate-sodium—Abdominal distension—Epirubicin—sarcoma	0.000683	0.00168	CcSEcCtD
Salicylate-sodium—Asthenia—Dactinomycin—sarcoma	0.000683	0.00168	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Mitoxantrone—sarcoma	0.000682	0.00168	CcSEcCtD
Salicylate-sodium—Blood creatinine increased—Doxorubicin—sarcoma	0.000681	0.00167	CcSEcCtD
Salicylate-sodium—Asthma—Epirubicin—sarcoma	0.000679	0.00167	CcSEcCtD
Salicylate-sodium—Dysphagia—Epirubicin—sarcoma	0.000679	0.00167	CcSEcCtD
Salicylate-sodium—Pruritus—Thiotepa—sarcoma	0.000678	0.00167	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000677	0.00166	CcSEcCtD
Salicylate-sodium—Dehydration—Doxorubicin—sarcoma	0.000676	0.00166	CcSEcCtD
Salicylate-sodium—Tachycardia—Etoposide—sarcoma	0.000672	0.00165	CcSEcCtD
Salicylate-sodium—Abdominal pain—Vincristine—sarcoma	0.000672	0.00165	CcSEcCtD
Salicylate-sodium—Body temperature increased—Vincristine—sarcoma	0.000672	0.00165	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Etoposide—sarcoma	0.000666	0.00164	CcSEcCtD
Salicylate-sodium—Abdominal pain upper—Doxorubicin—sarcoma	0.000664	0.00163	CcSEcCtD
Salicylate-sodium—Hypokalaemia—Doxorubicin—sarcoma	0.000661	0.00163	CcSEcCtD
Salicylate-sodium—Urticaria—Mitoxantrone—sarcoma	0.000658	0.00162	CcSEcCtD
Salicylate-sodium—Anorexia—Etoposide—sarcoma	0.000656	0.00161	CcSEcCtD
Salicylate-sodium—Diarrhoea—Thiotepa—sarcoma	0.000656	0.00161	CcSEcCtD
Salicylate-sodium—Abdominal pain—Mitoxantrone—sarcoma	0.000654	0.00161	CcSEcCtD
Salicylate-sodium—Body temperature increased—Mitoxantrone—sarcoma	0.000654	0.00161	CcSEcCtD
Salicylate-sodium—Bronchitis—Epirubicin—sarcoma	0.000653	0.0016	CcSEcCtD
Salicylate-sodium—Diarrhoea—Dactinomycin—sarcoma	0.000651	0.0016	CcSEcCtD
Salicylate-sodium—Hypotension—Etoposide—sarcoma	0.000643	0.00158	CcSEcCtD
Salicylate-sodium—Dizziness—Thiotepa—sarcoma	0.000634	0.00156	CcSEcCtD
Salicylate-sodium—Abdominal distension—Doxorubicin—sarcoma	0.000632	0.00155	CcSEcCtD
Salicylate-sodium—Dysphagia—Doxorubicin—sarcoma	0.000628	0.00154	CcSEcCtD
Salicylate-sodium—Asthma—Doxorubicin—sarcoma	0.000628	0.00154	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Vincristine—sarcoma	0.000626	0.00154	CcSEcCtD
Salicylate-sodium—Paraesthesia—Etoposide—sarcoma	0.000618	0.00152	CcSEcCtD
Salicylate-sodium—Weight increased—Epirubicin—sarcoma	0.000618	0.00152	CcSEcCtD
Salicylate-sodium—Dyspnoea—Etoposide—sarcoma	0.000614	0.00151	CcSEcCtD
Salicylate-sodium—Somnolence—Etoposide—sarcoma	0.000612	0.0015	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Mitoxantrone—sarcoma	0.00061	0.0015	CcSEcCtD
Salicylate-sodium—Asthenia—Vincristine—sarcoma	0.00061	0.0015	CcSEcCtD
Salicylate-sodium—Vomiting—Thiotepa—sarcoma	0.00061	0.0015	CcSEcCtD
Salicylate-sodium—Drowsiness—Epirubicin—sarcoma	0.000605	0.00149	CcSEcCtD
Salicylate-sodium—Vomiting—Dactinomycin—sarcoma	0.000605	0.00149	CcSEcCtD
Salicylate-sodium—Rash—Thiotepa—sarcoma	0.000604	0.00149	CcSEcCtD
Salicylate-sodium—Bronchitis—Doxorubicin—sarcoma	0.000604	0.00148	CcSEcCtD
Salicylate-sodium—Dermatitis—Thiotepa—sarcoma	0.000604	0.00148	CcSEcCtD
Salicylate-sodium—Headache—Thiotepa—sarcoma	0.000601	0.00148	CcSEcCtD
Salicylate-sodium—Rash—Dactinomycin—sarcoma	0.0006	0.00147	CcSEcCtD
Salicylate-sodium—Decreased appetite—Etoposide—sarcoma	0.000599	0.00147	CcSEcCtD
Salicylate-sodium—Renal failure—Epirubicin—sarcoma	0.000595	0.00146	CcSEcCtD
Salicylate-sodium—Asthenia—Mitoxantrone—sarcoma	0.000594	0.00146	CcSEcCtD
Salicylate-sodium—Fatigue—Etoposide—sarcoma	0.000594	0.00146	CcSEcCtD
Salicylate-sodium—Pain—Etoposide—sarcoma	0.000589	0.00145	CcSEcCtD
Salicylate-sodium—Constipation—Etoposide—sarcoma	0.000589	0.00145	CcSEcCtD
Salicylate-sodium—Diarrhoea—Vincristine—sarcoma	0.000582	0.00143	CcSEcCtD
Salicylate-sodium—Weight increased—Doxorubicin—sarcoma	0.000572	0.0014	CcSEcCtD
Salicylate-sodium—Epistaxis—Epirubicin—sarcoma	0.000571	0.0014	CcSEcCtD
Salicylate-sodium—Nausea—Thiotepa—sarcoma	0.000569	0.0014	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Etoposide—sarcoma	0.000567	0.00139	CcSEcCtD
Salicylate-sodium—Diarrhoea—Mitoxantrone—sarcoma	0.000566	0.00139	CcSEcCtD
Salicylate-sodium—Nausea—Dactinomycin—sarcoma	0.000565	0.00139	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Etoposide—sarcoma	0.000563	0.00138	CcSEcCtD
Salicylate-sodium—Dizziness—Vincristine—sarcoma	0.000562	0.00138	CcSEcCtD
Salicylate-sodium—Drowsiness—Doxorubicin—sarcoma	0.00056	0.00138	CcSEcCtD
Salicylate-sodium—Renal failure—Doxorubicin—sarcoma	0.00055	0.00135	CcSEcCtD
Salicylate-sodium—Urticaria—Etoposide—sarcoma	0.000547	0.00134	CcSEcCtD
Salicylate-sodium—Abdominal pain—Etoposide—sarcoma	0.000544	0.00134	CcSEcCtD
Salicylate-sodium—Body temperature increased—Etoposide—sarcoma	0.000544	0.00134	CcSEcCtD
Salicylate-sodium—Hepatitis—Epirubicin—sarcoma	0.000543	0.00134	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Epirubicin—sarcoma	0.000541	0.00133	CcSEcCtD
Salicylate-sodium—Vomiting—Vincristine—sarcoma	0.00054	0.00133	CcSEcCtD
Salicylate-sodium—Rash—Vincristine—sarcoma	0.000536	0.00132	CcSEcCtD
Salicylate-sodium—Dermatitis—Vincristine—sarcoma	0.000535	0.00132	CcSEcCtD
Salicylate-sodium—Headache—Vincristine—sarcoma	0.000533	0.00131	CcSEcCtD
Salicylate-sodium—Epistaxis—Doxorubicin—sarcoma	0.000528	0.0013	CcSEcCtD
Salicylate-sodium—Vomiting—Mitoxantrone—sarcoma	0.000526	0.00129	CcSEcCtD
Salicylate-sodium—Rash—Mitoxantrone—sarcoma	0.000522	0.00128	CcSEcCtD
Salicylate-sodium—Dermatitis—Mitoxantrone—sarcoma	0.000522	0.00128	CcSEcCtD
Salicylate-sodium—Headache—Mitoxantrone—sarcoma	0.000519	0.00127	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Epirubicin—sarcoma	0.000514	0.00126	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Etoposide—sarcoma	0.000507	0.00125	CcSEcCtD
Salicylate-sodium—Tinnitus—Epirubicin—sarcoma	0.000507	0.00125	CcSEcCtD
Salicylate-sodium—Nausea—Vincristine—sarcoma	0.000505	0.00124	CcSEcCtD
Salicylate-sodium—Hepatitis—Doxorubicin—sarcoma	0.000503	0.00124	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Doxorubicin—sarcoma	0.0005	0.00123	CcSEcCtD
Salicylate-sodium—Asthenia—Etoposide—sarcoma	0.000494	0.00121	CcSEcCtD
Salicylate-sodium—Nausea—Mitoxantrone—sarcoma	0.000492	0.00121	CcSEcCtD
Salicylate-sodium—Pruritus—Etoposide—sarcoma	0.000487	0.0012	CcSEcCtD
Salicylate-sodium—Arrhythmia—Epirubicin—sarcoma	0.000485	0.00119	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Doxorubicin—sarcoma	0.000475	0.00117	CcSEcCtD
Salicylate-sodium—Erythema—Epirubicin—sarcoma	0.000473	0.00116	CcSEcCtD
Salicylate-sodium—Diarrhoea—Etoposide—sarcoma	0.000471	0.00116	CcSEcCtD
Salicylate-sodium—Tinnitus—Doxorubicin—sarcoma	0.000469	0.00115	CcSEcCtD
Salicylate-sodium—Flatulence—Epirubicin—sarcoma	0.000466	0.00115	CcSEcCtD
Salicylate-sodium—Dysgeusia—Epirubicin—sarcoma	0.000463	0.00114	CcSEcCtD
Salicylate-sodium—Dizziness—Etoposide—sarcoma	0.000455	0.00112	CcSEcCtD
Salicylate-sodium—Arrhythmia—Doxorubicin—sarcoma	0.000449	0.0011	CcSEcCtD
Salicylate-sodium—Vision blurred—Epirubicin—sarcoma	0.000446	0.0011	CcSEcCtD
Salicylate-sodium—Vomiting—Etoposide—sarcoma	0.000438	0.00108	CcSEcCtD
Salicylate-sodium—Erythema—Doxorubicin—sarcoma	0.000438	0.00108	CcSEcCtD
Salicylate-sodium—Rash—Etoposide—sarcoma	0.000434	0.00107	CcSEcCtD
Salicylate-sodium—Dermatitis—Etoposide—sarcoma	0.000434	0.00107	CcSEcCtD
Salicylate-sodium—Headache—Etoposide—sarcoma	0.000431	0.00106	CcSEcCtD
Salicylate-sodium—Flatulence—Doxorubicin—sarcoma	0.000431	0.00106	CcSEcCtD
Salicylate-sodium—Dysgeusia—Doxorubicin—sarcoma	0.000429	0.00105	CcSEcCtD
Salicylate-sodium—Syncope—Epirubicin—sarcoma	0.000424	0.00104	CcSEcCtD
Salicylate-sodium—Palpitations—Epirubicin—sarcoma	0.000418	0.00103	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Epirubicin—sarcoma	0.000416	0.00102	CcSEcCtD
Salicylate-sodium—Vision blurred—Doxorubicin—sarcoma	0.000412	0.00101	CcSEcCtD
Salicylate-sodium—Convulsion—Epirubicin—sarcoma	0.00041	0.00101	CcSEcCtD
Salicylate-sodium—Nausea—Etoposide—sarcoma	0.000409	0.00101	CcSEcCtD
Salicylate-sodium—Chest pain—Epirubicin—sarcoma	0.000403	0.00099	CcSEcCtD
Salicylate-sodium—Anxiety—Epirubicin—sarcoma	0.000401	0.000986	CcSEcCtD
Salicylate-sodium—Syncope—Doxorubicin—sarcoma	0.000392	0.000965	CcSEcCtD
Salicylate-sodium—Confusional state—Epirubicin—sarcoma	0.000389	0.000957	CcSEcCtD
Salicylate-sodium—Palpitations—Doxorubicin—sarcoma	0.000387	0.000951	CcSEcCtD
Salicylate-sodium—Oedema—Epirubicin—sarcoma	0.000386	0.000949	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Epirubicin—sarcoma	0.000386	0.000949	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Doxorubicin—sarcoma	0.000385	0.000945	CcSEcCtD
Salicylate-sodium—Infection—Epirubicin—sarcoma	0.000383	0.000943	CcSEcCtD
Salicylate-sodium—Shock—Epirubicin—sarcoma	0.00038	0.000933	CcSEcCtD
Salicylate-sodium—Convulsion—Doxorubicin—sarcoma	0.000379	0.000932	CcSEcCtD
Salicylate-sodium—Tachycardia—Epirubicin—sarcoma	0.000377	0.000926	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Epirubicin—sarcoma	0.000373	0.000917	CcSEcCtD
Salicylate-sodium—Chest pain—Doxorubicin—sarcoma	0.000373	0.000916	CcSEcCtD
Salicylate-sodium—Anxiety—Doxorubicin—sarcoma	0.000371	0.000913	CcSEcCtD
Salicylate-sodium—Anorexia—Epirubicin—sarcoma	0.000368	0.000904	CcSEcCtD
Salicylate-sodium—Hypotension—Epirubicin—sarcoma	0.000361	0.000887	CcSEcCtD
Salicylate-sodium—Confusional state—Doxorubicin—sarcoma	0.00036	0.000885	CcSEcCtD
Salicylate-sodium—Oedema—Doxorubicin—sarcoma	0.000357	0.000878	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Doxorubicin—sarcoma	0.000357	0.000878	CcSEcCtD
Salicylate-sodium—Infection—Doxorubicin—sarcoma	0.000355	0.000872	CcSEcCtD
Salicylate-sodium—Shock—Doxorubicin—sarcoma	0.000351	0.000864	CcSEcCtD
Salicylate-sodium—Tachycardia—Doxorubicin—sarcoma	0.000349	0.000857	CcSEcCtD
Salicylate-sodium—Paraesthesia—Epirubicin—sarcoma	0.000347	0.000852	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Doxorubicin—sarcoma	0.000345	0.000849	CcSEcCtD
Salicylate-sodium—Dyspnoea—Epirubicin—sarcoma	0.000344	0.000846	CcSEcCtD
Salicylate-sodium—Somnolence—Epirubicin—sarcoma	0.000343	0.000843	CcSEcCtD
Salicylate-sodium—Anorexia—Doxorubicin—sarcoma	0.00034	0.000837	CcSEcCtD
Salicylate-sodium—Dyspepsia—Epirubicin—sarcoma	0.00034	0.000835	CcSEcCtD
Salicylate-sodium—Decreased appetite—Epirubicin—sarcoma	0.000336	0.000825	CcSEcCtD
Salicylate-sodium—Hypotension—Doxorubicin—sarcoma	0.000334	0.00082	CcSEcCtD
Salicylate-sodium—Fatigue—Epirubicin—sarcoma	0.000333	0.000818	CcSEcCtD
Salicylate-sodium—Constipation—Epirubicin—sarcoma	0.00033	0.000811	CcSEcCtD
Salicylate-sodium—Pain—Epirubicin—sarcoma	0.00033	0.000811	CcSEcCtD
Salicylate-sodium—Paraesthesia—Doxorubicin—sarcoma	0.000321	0.000788	CcSEcCtD
Salicylate-sodium—Dyspnoea—Doxorubicin—sarcoma	0.000318	0.000783	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Epirubicin—sarcoma	0.000318	0.000782	CcSEcCtD
Salicylate-sodium—Somnolence—Doxorubicin—sarcoma	0.000318	0.00078	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Epirubicin—sarcoma	0.000316	0.000776	CcSEcCtD
Salicylate-sodium—Dyspepsia—Doxorubicin—sarcoma	0.000314	0.000773	CcSEcCtD
Salicylate-sodium—Decreased appetite—Doxorubicin—sarcoma	0.00031	0.000763	CcSEcCtD
Salicylate-sodium—Fatigue—Doxorubicin—sarcoma	0.000308	0.000757	CcSEcCtD
Salicylate-sodium—Urticaria—Epirubicin—sarcoma	0.000307	0.000754	CcSEcCtD
Salicylate-sodium—Pain—Doxorubicin—sarcoma	0.000305	0.000751	CcSEcCtD
Salicylate-sodium—Constipation—Doxorubicin—sarcoma	0.000305	0.000751	CcSEcCtD
Salicylate-sodium—Body temperature increased—Epirubicin—sarcoma	0.000305	0.00075	CcSEcCtD
Salicylate-sodium—Abdominal pain—Epirubicin—sarcoma	0.000305	0.00075	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Doxorubicin—sarcoma	0.000294	0.000723	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Doxorubicin—sarcoma	0.000292	0.000718	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Epirubicin—sarcoma	0.000284	0.000699	CcSEcCtD
Salicylate-sodium—Urticaria—Doxorubicin—sarcoma	0.000284	0.000697	CcSEcCtD
Salicylate-sodium—Abdominal pain—Doxorubicin—sarcoma	0.000282	0.000694	CcSEcCtD
Salicylate-sodium—Body temperature increased—Doxorubicin—sarcoma	0.000282	0.000694	CcSEcCtD
Salicylate-sodium—Asthenia—Epirubicin—sarcoma	0.000277	0.000681	CcSEcCtD
Salicylate-sodium—Pruritus—Epirubicin—sarcoma	0.000273	0.000671	CcSEcCtD
Salicylate-sodium—Diarrhoea—Epirubicin—sarcoma	0.000264	0.000649	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Doxorubicin—sarcoma	0.000263	0.000647	CcSEcCtD
Salicylate-sodium—Asthenia—Doxorubicin—sarcoma	0.000256	0.00063	CcSEcCtD
Salicylate-sodium—Dizziness—Epirubicin—sarcoma	0.000255	0.000627	CcSEcCtD
Salicylate-sodium—Pruritus—Doxorubicin—sarcoma	0.000253	0.000621	CcSEcCtD
Salicylate-sodium—Vomiting—Epirubicin—sarcoma	0.000245	0.000603	CcSEcCtD
Salicylate-sodium—Diarrhoea—Doxorubicin—sarcoma	0.000244	0.000601	CcSEcCtD
Salicylate-sodium—Rash—Epirubicin—sarcoma	0.000243	0.000598	CcSEcCtD
Salicylate-sodium—Dermatitis—Epirubicin—sarcoma	0.000243	0.000598	CcSEcCtD
Salicylate-sodium—Headache—Epirubicin—sarcoma	0.000242	0.000594	CcSEcCtD
Salicylate-sodium—Dizziness—Doxorubicin—sarcoma	0.000236	0.00058	CcSEcCtD
Salicylate-sodium—Nausea—Epirubicin—sarcoma	0.000229	0.000564	CcSEcCtD
Salicylate-sodium—Vomiting—Doxorubicin—sarcoma	0.000227	0.000558	CcSEcCtD
Salicylate-sodium—Rash—Doxorubicin—sarcoma	0.000225	0.000553	CcSEcCtD
Salicylate-sodium—Dermatitis—Doxorubicin—sarcoma	0.000225	0.000553	CcSEcCtD
Salicylate-sodium—Headache—Doxorubicin—sarcoma	0.000224	0.00055	CcSEcCtD
Salicylate-sodium—Nausea—Doxorubicin—sarcoma	0.000212	0.000521	CcSEcCtD
